Insider · CIK 0001867686
John R Haines
Files at CELU (Celularity Inc). First filing -, latest -.
In brief
John R Haines files SEC Form 4 as officer at CELU (Celularity Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John R Haines has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | CELU Celularity Inc | MOption exercise Class A Common Stock | +1,641 | $0.00 | $0 | 30,762 | Apr 15, 2026 |
| Apr 13, 2026 | CELU Celularity Inc | FTax withholding Class A Common Stock | -583 | $1.28 | $746 | 30,179 | Apr 15, 2026 |
| Apr 13, 2026 | CELU Celularity Inc | MOption exercise Restricted Stock Unitsderivative | -1,641 | $0.00 | $0 | 0 | Apr 15, 2026 |
| Apr 13, 2025 | CELU Celularity Inc | MOption exercise Class A Common Stock | +1,641 | $0.00 | $0 | 29,698 | Apr 15, 2025 |
| Apr 13, 2025 | CELU Celularity Inc | FTax withholding Class A Common Stock | -577 | $1.64 | $946 | 29,121 | Apr 15, 2025 |
| Apr 13, 2025 | CELU Celularity Inc | MOption exercise Restricted Stock Unitsderivative | -1,641 | $0.00 | $0 | 1,641 | Apr 15, 2025 |
| Feb 17, 2025 | CELU Celularity Inc | MOption exercise Class A Common Stock | +20,000 | $0.00 | $0 | 35,092 | Feb 19, 2025 |
| Feb 17, 2025 | CELU Celularity Inc | FTax withholding Class A Common Stock | -7,035 | $2.14 | $15k | 28,057 | Feb 19, 2025 |
| Feb 17, 2025 | CELU Celularity Inc | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 0 | Feb 19, 2025 |
| Apr 13, 2024 | CELU Celularity Inc | FTax withholding Class A Common Stock | -576 | $4.11 | $2,367 | 38,373 | Apr 16, 2024 |
| Feb 17, 2024 | CELU Celularity Inc | FTax withholding Class A Common Stock | -70,350 | $0.43 | $31k | 389,497 | Feb 21, 2024 |
| Feb 16, 2024 | CELU Celularity Inc | AGrant or award Stock Option Grant (Right to Buy)derivative | +216,014 | $0.00 | $0 | 216,014 | Feb 21, 2024 |
Questions about John R Haines
Answered from the filings on this page, as of the latest one.
Is John R Haines buying or selling?
John R Haines has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John R Haines's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John R Haines has 0.
Where does John R Haines file Form 4?
John R Haines has filed Form 4 at CELU (Celularity Inc) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.